CA
ELDN icon

Cliff Asness’s Eledon Pharmaceuticals ELDN Stock Holding History

Cliff Asness’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.29M Buy
581,028
+408,611
+237% +$1.49M ﹤0.01% 2541
2026
Q1 		$531K Buy
172,417
+112,202
+186% +$264K ﹤0.01% 3087
2025
Q4 		$90.9K Buy
+60,215
New +$143K ﹤0.01% 3468

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CCM
Catalio Capital Management New York $532M AUM 166.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ZP
Zimmer Partners New York $4.34B AUM 22.78% 1-Year Est. Return

Cliff Asness's ELDN Position: Q2 2026 in Review

Cliff Asness increased its Eledon Pharmaceuticals (ELDN) stake by 237% in Q2 2026, buying an estimated $1.49M and bringing the position to 581,028 shares worth $2.29M. The position accounts for ﹤0.01% of the portfolio, ranked #2541.

Cliff Asness first reported a position in ELDN in Q4 2025 and has held it in 3 quarters since. 159 funds tracked by Wall St. Rank hold ELDN as of Q2 2026.

  • Cliff Asness held 581,028 shares of Eledon Pharmaceuticals worth $2.29M as of Q2 2026.
  • Cliff Asness bought 408,611 Eledon Pharmaceuticals shares in Q2 2026, an estimated $1.49M.
  • Eledon Pharmaceuticals made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #2541 holding.
  • Cliff Asness first reported a position in Eledon Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 159 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.